About Us
Our profit with purpose-led strategy has a singular impact objective – to reduce the inequitable, social, and economic burden of non-communicable diseases on communities globally, helping people enjoy longer, healthier lives and driving more efficient and stronger health systems.
Our Mission
We are working to help people lead longer, healthier lives through innovative, affordable and scalable healthcare solutions that can transform treatments and drive stronger health systems, with a focus on those with the greatest need.
Profit with Purpose
Tremendous results can be achieved if we balance profit and purpose towards achieving healthier living for all. We believe there should be no boundaries between business and social impact. Being a sustainable and profitable company is what enables us to continue delivering on our mission over the long term.
Our Businesses
With a portfolio of three commercial businesses – George Clinical, George Medicines and Ellen Medical Devices – underpinned by exclusive access to the scientific expertise of world-leading medical research institute, The George Institute for Global Health, we can provide high-quality, affordable healthcare solutions, including treatments, devices and services at scale.
Non-communicable diseases –
a unique 21st century global health challenge
US$47 trillion
The United Nations has projected that cumulative losses to the global economy due to chronic disease could reach US$47 trillion by 2030.
4 billion
1/2 the world’s population does not have access to the health services it needs.
Each year, 100 million people are pushed into poverty because of out-of-pocket health costs.
Each year, 100 million people are pushed into poverty because of out-of-pocket health costs.
100 million
100 million people will die from chronic diseases before they reach 60.
Heart attack and stroke are the world’s leading causes of death.
Heart attack and stroke are the world’s leading causes of death.
